Literature DB >> 16679768

Cerebellar neurons and glial cells are transducible by lentiviral vectors without decrease of cerebellar functions.

C Croci1, S Fasano, D Superchi, L Perani, A Martellosio, R Brambilla, G Consalez, E R Bongarzone.   

Abstract

Due to the profuse connections of the cerebellum to the rest of the central nervous system, cerebellar dysfunction impacts tremendously on movement coordination, maintenance of equilibrium, muscle tone and motor memory. Efficient gene transfer of therapeutic genes to this central nervous system structure would constitute a relevant step ahead the design of treatments to ameliorate cerebellar dysfunction. Lentiviral vectors (LVs) have been used as efficient vehicles to integrate transgenes into dividing and non-dividing cells, such as postmitotic adult neurons, with minimal toxicity and immune response. This study aimed to use LVs carrying green fluorescent protein (GFP) cDNA for transduction of cerebellar cells in vivo without compromising neurological cerebellar functions. Our results indicate that LVs, injected in the lobulus simplex, transduced different cerebellar neurons including stellate, Purkinje cells, granular neurons and glial cells such as astrocytes, oligodendrocytes, and that this gene transfer approach was not accompanied by cerebellar deficits. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16679768     DOI: 10.1159/000091919

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  11 in total

1.  Gene transfer to the cerebellum.

Authors:  Jean-Pierre Louboutin; Beverly A S Reyes; Elisabeth J Van Bockstaele; David S Strayer
Journal:  Cerebellum       Date:  2010-12       Impact factor: 3.847

2.  High transgene expression by lentiviral vectors causes maldevelopment of Purkinje cells in vivo.

Authors:  Yusuke Sawada; Go Kajiwara; Akira Iizuka; Kiyohiko Takayama; Anton N Shuvaev; Chiho Koyama; Hirokazu Hirai
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

3.  Effects of irradiation on the postnatal development of the brain in a genetic mouse model of globoid cell leukodystrophy.

Authors:  Francesca Galbiati; Giulia Clementi; Daniela Superchi; Maria I Givogri; Ernesto R Bongarzone
Journal:  Neurochem Res       Date:  2007-01-03       Impact factor: 3.996

Review 4.  Recent developments in the understanding of astrocyte function in the cerebellum in vivo.

Authors:  Tycho M Hoogland; Bernd Kuhn
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

Review 5.  Dendrite formation of cerebellar Purkinje cells.

Authors:  Masahiko Tanaka
Journal:  Neurochem Res       Date:  2009-10-10       Impact factor: 3.996

6.  Transfection of nerve cells.

Authors:  S V Salozhin; A P Bol'shakov
Journal:  Neurosci Behav Physiol       Date:  2010-02-10

7.  Maternal immune activation produces cerebellar hyperplasia and alterations in motor and social behaviors in male and female mice.

Authors:  Tooka Aavani; Shadna A Rana; Richard Hawkes; Quentin J Pittman
Journal:  Cerebellum       Date:  2015-10       Impact factor: 3.847

Review 8.  Redefining the cerebellar cortex as an assembly of non-uniform Purkinje cell microcircuits.

Authors:  Nadia L Cerminara; Eric J Lang; Roy V Sillitoe; Richard Apps
Journal:  Nat Rev Neurosci       Date:  2015-02       Impact factor: 34.870

9.  Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer.

Authors:  Marco Ranzani; Daniela Cesana; Cynthia C Bartholomae; Francesca Sanvito; Mauro Pala; Fabrizio Benedicenti; Pierangela Gallina; Lucia Sergi Sergi; Stefania Merella; Alessandro Bulfone; Claudio Doglioni; Christof von Kalle; Yoon Jun Kim; Manfred Schmidt; Giovanni Tonon; Luigi Naldini; Eugenio Montini
Journal:  Nat Methods       Date:  2013-01-13       Impact factor: 28.547

10.  Dual transgene expression in murine cerebellar Purkinje neurons by viral transduction in vivo.

Authors:  Marie K Bosch; Jeanne M Nerbonne; David M Ornitz
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.